Reet Koomägi
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 10
- Cancer, Lipids, and Metabolism 7
- Oncology top 5%
- Cancer-related Molecular Pathways 13
- Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer 15
- RNA modifications and cancer 9
- Kruppel-like factors research 5
- Internal Medicine top 10%
- Hepatology top 5%
-
- Lung Cancer Treatments and Mutations 9
-
- Cancer Research and Treatments 5
Reet Koomägi
58 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 93
- Cancer Research 675
- Oncology 766
- Molecular Biology 1.3k
- Internal Medicine 60
- Hepatology 118
Countries citing papers authored by Reet Koomägi
This map shows the geographic impact of Reet Koomägi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reet Koomägi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reet Koomägi more than expected).
Fields of papers citing papers by Reet Koomägi
This network shows the impact of papers produced by Reet Koomägi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reet Koomägi. The network helps show where Reet Koomägi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Reet Koomägi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 0 | |
| 2 | 2003 | 3 | |
| 3 | 2003 | 1 | |
| 4 | 2002 | 12 | |
| 5 | 2002 | 5 | |
| 6 | Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. | 2002 | 39 |
| 7 | 2002 | 50 | |
| 8 | 2000 | 57 | |
| 9 | 1999 | 8 | |
| 10 | 1998 | 23 | |
| 11 | 1997 | 184 | |
| 12 | 1997 | 11 | |
| 13 | 1997 | 24 | |
| 14 | 1997 | 38 | |
| 15 | Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. | 1997 | 39 |
| 16 | 1997 | 87 | |
| 17 | 1996 | 12 | |
| 18 | 1996 | 263 | |
| 19 | 1995 | 20 | |
| 20 | 1995 | 13 |
About Reet Koomägi
Reet Koomägi is a scholar working on Cancer Research, Oncology, Molecular Biology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 59 papers that have together received 2.0k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (15 papers), Cancer-related Molecular Pathways (13 papers), Cancer, Hypoxia, and Metabolism (10 papers), Lung Cancer Treatments and Mutations (9 papers), RNA modifications and cancer (9 papers), Cancer, Lipids, and Metabolism (7 papers), Kruppel-like factors research (5 papers) and Cancer Research and Treatments (5 papers). The work is most often cited by research in Cancer Research (675 citations), Oncology (766 citations), Molecular Biology (1.3k citations), Internal Medicine (60 citations) and Hepatology (118 citations). Reet Koomägi has collaborated with scholars based in Germany, Estonia and Iran. Frequent co-authors include M Volm, J Mattern, G. Stammler, Jürgen Mattern, Thomas Efferth, M Volm, Axel Sauerbrey, Werner Rittgen, Monica Hollstein and Abdolamir Allameh. Their work appears in journals such as International Journal of Oncology, International Journal of Cancer, Oncology Reports, British Journal of Cancer and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.